tiprankstipranks
Incyte (INCY)
NASDAQ:INCY
US Market
INCY
Incyte
RESEARCH TOOLSreports
Want to see INCY full AI Analyst Report?

Incyte (INCY) Stock News & Sentiment

1,913 Followers
Incyte’s Ruxolitinib Cream Delivers Strong Phase 3b Eczema Data, Supporting Dermatology Upside for INCY
Premium
Company Announcements
Incyte’s Ruxolitinib Cream Delivers Strong Phase 3b Eczema Data, Supporting Dermatology Upside for INCY
3d ago
INCY
Incyte Targets KRAS G12D Pancreatic Cancer With New Phase 3 DAWN-303 Trial
Premium
Company Announcements
Incyte Targets KRAS G12D Pancreatic Cancer With New Phase 3 DAWN-303 Trial
17d ago
INCY
Incyte: Buy Rating Reaffirmed as Pipeline Strength and Long-Term Visibility Drive Price Target Increase to $124
Premium
Ratings
Incyte: Buy Rating Reaffirmed as Pipeline Strength and Long-Term Visibility Drive Price Target Increase to $124
27d ago
INCY
Incyte Earnings Call Highlights Broad Growth, Rising Risks
Premium
Company Announcements
Incyte Earnings Call Highlights Broad Growth, Rising Risks
27d ago
INCY
INCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
INCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
30d ago
INCY
Incyte, BNY Mellon, Quantum-Si, Jabil, Levi Shock
Premium
Weekend Updates
Incyte, BNY Mellon, Quantum-Si, Jabil, Levi Shock
1M ago
BK
JBL
Bullish View on Povorcitinib’s Broad HS Adoption and Manageable JAK Safety Supports $135 Target
Premium
Ratings
Bullish View on Povorcitinib’s Broad HS Adoption and Manageable JAK Safety Supports $135 Target
1M ago
INCY
More INCY News >

INCY News on the Web

Incyte Sets Mid-Year Phase 3 Trial for CALR Antibody 989 as Pipeline Updates Roll Out
MarketBeat
Bullish
Incyte’s Ruxolitinib Cream Delivers Strong Phase 3b Eczema Data, Supporting Dermatology Upside for INCY
TipRanks News
Bullish
Top Incyte Insider Makes Major Move With Fresh Stock Sale
TipRanks News
Bullish
Bernstein starts Incyte at MarketPerform, sees no clear path for revenue rebound
TipRanks News
Bearish
Incyte initiated with a Market Perform at Bernstein
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Kindly MD (NAKA) and Roivant Sciences (ROIV)
TipRanks News
Bullish
Incyte (INCY) Expands AI Drug Discovery Partnership with Genesis Molecular AI
GuruFocus News
Bullish
Incyte, Genesis Molecular AI announce expansion of collaboration
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
INCY
Sector Average
Media Buzz
This Week10 articles
Weekly Average12.75 articles
News Sentiment
This Week79%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is INCY’s Media Buzz Sentiment?
10 articles about INCY were published this week. In an average week, 12.75 articles are published.
    What is INCY’s weekly average amount of articles?
    In an average week, 12.75 articles about INCY are published.
      What is INCY’s News Sentiment?
      79% of articles about INCY were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week